Clarametyx 2020-06: Efficacy of Novel Antibody(s) in the Rodent Models of Bacterial Infection

Project Details

StatusFinished
Effective start/end date21/09/20 → 20/09/21

Funding

  • Clarametyx Biosciences, Inc.: $121,924.22

Keywords

  • Biotechnology & Drug Development, Infectious Diseases